11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

✍ Scribed by Juha O Rinne; David J Brooks; Martin N Rossor; Nick C Fox; Roger Bullock; William E Klunk; Chester A Mathis; Kaj Blennow; Jerome Barakos; Aren A Okello; Sofia Rodriguez Martinez de LIano; Enchi Liu; Martin Koller; Keith M Gregg; Dale Schenk; Ronald Black; Michael Grundman

• Book ID: 114409457
• Publisher: The Lancet
• Year: 2010
• Tongue: English
• Weight: 496 KB
• Volume: 9
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/s1474-4422(10)70043-0